Inside Precision Medicine September 13, 2022
The Taiwan Precision Medicine Initiative (TPMI), which has a goal of genotyping one million people to develop relevant genomic data to help power the delivery of precision medicine on the island nation, announced today it has chosen Thermo Fisher Scientific as a scientific partner to provide genotyping services for the program.
In July, TPMI announced it had enrolled more than 500,000 participants making it the largest study of its kind outside the United States and Europe. The program is an important effort that will help build genomic data sets of diverse populations—in this case the Han Chinese people who represent approximately 18% of the global population—to optimize the delivery of targeted treatments.
“The healthcare community is working toward proving the...
Today's Sponsors
Today's Sponsor